Publication Information

{'id': 'https://openalex.org/W2503626267', 'doi': 'https://doi.org/10.1158/1538-7445.am2016-268', 'title': 'Abstract 268: PARP3 inhibitors in cancer therapy', 'display_name': 'Abstract 268: PARP3 inhibitors in cancer therapy', 'publication_year': 2016, 'publication_date': '2016-07-15', 'ids': {'openalex': 'https://openalex.org/W2503626267', 'doi': 'https://doi.org/10.1158/1538-7445.am2016-268', 'mag': '2503626267'}, 'language': 'en', 'primary_location': {'is_oa': False, 'landing_page_url': 'https://doi.org/10.1158/1538-7445.am2016-268', 'pdf_url': None, 'source': {'id': 'https://openalex.org/S168522863', 'display_name': 'Cancer Research', 'issn_l': '0008-5472', 'issn': ['0008-5472', '1538-7445'], 'is_oa': False, 'is_in_doaj': False, 'is_core': True, 'host_organization': 'https://openalex.org/P4310320273', 'host_organization_name': 'American Association for Cancer Research', 'host_organization_lineage': ['https://openalex.org/P4310320273'], 'host_organization_lineage_names': ['American Association for Cancer Research'], 'type': 'journal'}, 'license': None, 'license_id': None, 'version': None, 'is_accepted': False, 'is_published': False}, 'type': 'article', 'type_crossref': 'journal-article', 'indexed_in': ['crossref'], 'open_access': {'is_oa': False, 'oa_status': 'closed', 'oa_url': None, 'any_repository_has_fulltext': False}, 'authorships': [{'author_position': 'first', 'author': {'id': 'https://openalex.org/A5042608851', 'display_name': 'Bahram Sharif-Askari', 'orcid': None}, 'institutions': [{'id': 'https://openalex.org/I5023651', 'display_name': 'McGill University', 'ror': 'https://ror.org/01pxwe438', 'country_code': 'CA', 'type': 'education', 'lineage': ['https://openalex.org/I5023651']}], 'countries': ['CA'], 'is_corresponding': False, 'raw_author_name': 'Bahram Sharif-Askari', 'raw_affiliation_strings': ['Faculty of Medicine, Department of Oncology, McGill University, Segal Cancer Center, Lady Davis Institute, Montréal, Quebec, Canada.'], 'affiliations': [{'raw_affiliation_string': 'Faculty of Medicine, Department of Oncology, McGill University, Segal Cancer Center, Lady Davis Institute, Montréal, Quebec, Canada.', 'institution_ids': ['https://openalex.org/I5023651']}]}, {'author_position': 'middle', 'author': {'id': 'https://openalex.org/A5042063888', 'display_name': 'David Davidson', 'orcid': None}, 'institutions': [{'id': 'https://openalex.org/I5023651', 'display_name': 'McGill University', 'ror': 'https://ror.org/01pxwe438', 'country_code': 'CA', 'type': 'education', 'lineage': ['https://openalex.org/I5023651']}], 'countries': ['CA'], 'is_corresponding': False, 'raw_author_name': 'David Davidson', 'raw_affiliation_strings': ['Faculty of Medicine, Department of Oncology, McGill University, Segal Cancer Center, Lady Davis Institute, Montréal, Quebec, Canada.'], 'affiliations': [{'raw_affiliation_string': 'Faculty of Medicine, Department of Oncology, McGill University, Segal Cancer Center, Lady Davis Institute, Montréal, Quebec, Canada.', 'institution_ids': ['https://openalex.org/I5023651']}]}, {'author_position': 'middle', 'author': {'id': 'https://openalex.org/A5027266640', 'display_name': 'Lilian Amrein', 'orcid': None}, 'institutions': [{'id': 'https://openalex.org/I5023651', 'display_name': 'McGill University', 'ror': 'https://ror.org/01pxwe438', 'country_code': 'CA', 'type': 'education', 'lineage': ['https://openalex.org/I5023651']}], 'countries': ['CA'], 'is_corresponding': False, 'raw_author_name': 'Lilian Amrein', 'raw_affiliation_strings': ['Faculty of Medicine, Department of Oncology, McGill University, Segal Cancer Center, Lady Davis Institute, Montréal, Quebec, Canada.'], 'affiliations': [{'raw_affiliation_string': 'Faculty of Medicine, Department of Oncology, McGill University, Segal Cancer Center, Lady Davis Institute, Montréal, Quebec, Canada.', 'institution_ids': ['https://openalex.org/I5023651']}]}, {'author_position': 'last', 'author': {'id': 'https://openalex.org/A5049481562', 'display_name': 'Lawrence Panasci', 'orcid': 'https://orcid.org/0000-0002-5141-5594'}, 'institutions': [{'id': 'https://openalex.org/I5023651', 'display_name': 'McGill University', 'ror': 'https://ror.org/01pxwe438', 'country_code': 'CA', 'type': 'education', 'lineage': ['https://openalex.org/I5023651']}], 'countries': ['CA'], 'is_corresponding': False, 'raw_author_name': 'Lawrence Panasci', 'raw_affiliation_strings': ['Faculty of Medicine, Department of Oncology, McGill University, Segal Cancer Center, Lady Davis Institute, Montréal, Quebec, Canada.'], 'affiliations': [{'raw_affiliation_string': 'Faculty of Medicine, Department of Oncology, McGill University, Segal Cancer Center, Lady Davis Institute, Montréal, Quebec, Canada.', 'institution_ids': ['https://openalex.org/I5023651']}]}], 'institution_assertions': [], 'countries_distinct_count': 1, 'institutions_distinct_count': 1, 'corresponding_author_ids': [], 'corresponding_institution_ids': [], 'apc_list': None, 'apc_paid': None, 'fwci': 0.0, 'has_fulltext': False, 'cited_by_count': 0, 'citation_normalized_percentile': {'value': 0.0, 'is_in_top_1_percent': False, 'is_in_top_10_percent': False}, 'cited_by_percentile_year': {'min': 0, 'max': 66}, 'biblio': {'volume': '76', 'issue': '14_Supplement', 'first_page': '268', 'last_page': '268'}, 'is_retracted': False, 'is_paratext': False, 'primary_topic': {'id': 'https://openalex.org/T11914', 'display_name': 'PARP inhibition in cancer therapy', 'score': 0.9986, 'subfield': {'id': 'https://openalex.org/subfields/2730', 'display_name': 'Oncology'}, 'field': {'id': 'https://openalex.org/fields/27', 'display_name': 'Medicine'}, 'domain': {'id': 'https://openalex.org/domains/4', 'display_name': 'Health Sciences'}}, 'topics': [{'id': 'https://openalex.org/T11914', 'display_name': 'PARP inhibition in cancer therapy', 'score': 0.9986, 'subfield': {'id': 'https://openalex.org/subfields/2730', 'display_name': 'Oncology'}, 'field': {'id': 'https://openalex.org/fields/27', 'display_name': 'Medicine'}, 'domain': {'id': 'https://openalex.org/domains/4', 'display_name': 'Health Sciences'}}, {'id': 'https://openalex.org/T10123', 'display_name': 'DNA Repair Mechanisms', 'score': 0.9172, 'subfield': {'id': 'https://openalex.org/subfields/1312', 'display_name': 'Molecular Biology'}, 'field': {'id': 'https://openalex.org/fields/13', 'display_name': 'Biochemistry, Genetics and Molecular Biology'}, 'domain': {'id': 'https://openalex.org/domains/1', 'display_name': 'Life Sciences'}}], 'keywords': [{'id': 'https://openalex.org/keywords/parp1', 'display_name': 'PARP1', 'score': 0.6804806}, {'id': 'https://openalex.org/keywords/ku80', 'display_name': 'Ku80', 'score': 0.5226621}, {'id': 'https://openalex.org/keywords/ku70', 'display_name': 'Ku70', 'score': 0.4583982}], 'concepts': [{'id': 'https://openalex.org/C143425029', 'wikidata': 'https://www.wikidata.org/wiki/Q5205747', 'display_name': 'DNA damage', 'level': 3, 'score': 0.7707795}, {'id': 'https://openalex.org/C182979987', 'wikidata': 'https://www.wikidata.org/wiki/Q3907241', 'display_name': 'Poly ADP ribose polymerase', 'level': 4, 'score': 0.68926007}, {'id': 'https://openalex.org/C2778480876', 'wikidata': 'https://www.wikidata.org/wiki/Q21112674', 'display_name': 'PARP1', 'level': 5, 'score': 0.6804806}, {'id': 'https://openalex.org/C134935766', 'wikidata': 'https://www.wikidata.org/wiki/Q210538', 'display_name': 'DNA repair', 'level': 3, 'score': 0.5725636}, {'id': 'https://openalex.org/C193104389', 'wikidata': 'https://www.wikidata.org/wiki/Q18032397', 'display_name': 'Ku80', 'level': 5, 'score': 0.5226621}, {'id': 'https://openalex.org/C153911025', 'wikidata': 'https://www.wikidata.org/wiki/Q7202', 'display_name': 'Molecular biology', 'level': 1, 'score': 0.48912722}, {'id': 'https://openalex.org/C2780919815', 'wikidata': 'https://www.wikidata.org/wiki/Q6440930', 'display_name': 'Ku70', 'level': 4, 'score': 0.4583982}, {'id': 'https://openalex.org/C109316439', 'wikidata': 'https://www.wikidata.org/wiki/Q246181', 'display_name': 'Cytotoxicity', 'level': 3, 'score': 0.4500858}, {'id': 'https://openalex.org/C552990157', 'wikidata': 'https://www.wikidata.org/wiki/Q7430', 'display_name': 'DNA', 'level': 2, 'score': 0.41475}, {'id': 'https://openalex.org/C185592680', 'wikidata': 'https://www.wikidata.org/wiki/Q2329', 'display_name': 'Chemistry', 'level': 0, 'score': 0.40412503}, {'id': 'https://openalex.org/C86803240', 'wikidata': 'https://www.wikidata.org/wiki/Q420', 'display_name': 'Biology', 'level': 0, 'score': 0.40044504}, {'id': 'https://openalex.org/C502942594', 'wikidata': 'https://www.wikidata.org/wiki/Q3421914', 'display_name': 'Cancer research', 'level': 1, 'score': 0.33808827}, {'id': 'https://openalex.org/C55493867', 'wikidata': 'https://www.wikidata.org/wiki/Q7094', 'display_name': 'Biochemistry', 'level': 1, 'score': 0.32330686}, {'id': 'https://openalex.org/C82381507', 'wikidata': 'https://www.wikidata.org/wiki/Q416878', 'display_name': 'Polymerase', 'level': 3, 'score': 0.25152385}, {'id': 'https://openalex.org/C202751555', 'wikidata': 'https://www.wikidata.org/wiki/Q221681', 'display_name': 'In vitro', 'level': 2, 'score': 0.16669527}, {'id': 'https://openalex.org/C94966510', 'wikidata': 'https://www.wikidata.org/wiki/Q2252764', 'display_name': 'DNA-binding protein', 'level': 4, 'score': 0.15304834}, {'id': 'https://openalex.org/C86339819', 'wikidata': 'https://www.wikidata.org/wiki/Q407384', 'display_name': 'Transcription factor', 'level': 3, 'score': 0.098920226}, {'id': 'https://openalex.org/C104317684', 'wikidata': 'https://www.wikidata.org/wiki/Q7187', 'display_name': 'Gene', 'level': 2, 'score': 0.0}], 'mesh': [], 'locations_count': 1, 'locations': [{'is_oa': False, 'landing_page_url': 'https://doi.org/10.1158/1538-7445.am2016-268', 'pdf_url': None, 'source': {'id': 'https://openalex.org/S168522863', 'display_name': 'Cancer Research', 'issn_l': '0008-5472', 'issn': ['0008-5472', '1538-7445'], 'is_oa': False, 'is_in_doaj': False, 'is_core': True, 'host_organization': 'https://openalex.org/P4310320273', 'host_organization_name': 'American Association for Cancer Research', 'host_organization_lineage': ['https://openalex.org/P4310320273'], 'host_organization_lineage_names': ['American Association for Cancer Research'], 'type': 'journal'}, 'license': None, 'license_id': None, 'version': None, 'is_accepted': False, 'is_published': False}], 'best_oa_location': None, 'sustainable_development_goals': [{'score': 0.61, 'id': 'https://metadata.un.org/sdg/3', 'display_name': 'Good health and well-being'}], 'grants': [], 'datasets': [], 'versions': [], 'referenced_works_count': 0, 'referenced_works': [], 'related_works': ['https://openalex.org/W4387397534', 'https://openalex.org/W4292541213', 'https://openalex.org/W2995060953', 'https://openalex.org/W2559189553', 'https://openalex.org/W2133490262', 'https://openalex.org/W2120319312', 'https://openalex.org/W2091068450', 'https://openalex.org/W2058592969', 'https://openalex.org/W1987617572', 'https://openalex.org/W1966254852'], 'abstract_inverted_index': {'Abstract': [0], 'Poly-ADP-ribose-polymerase': [1], '(PARP1)': [2], 'is': [3, 28, 62], 'an': [4], 'important': [5], 'regulator': [6], 'of': [7, 14, 17, 53, 70, 138, 179, 181, 197, 205, 216, 228, 286, 324, 337, 366, 374, 392, 413, 419, 431, 456, 461], 'DNA': [8, 18, 33, 58, 96, 376, 423], 'damage': [9], 'response': [10], '(DDR).': [11], 'After': [12], 'induction': [13], 'certain': [15], 'types': [16], 'damage,': [19], 'including': [20], 'nicks': [21], 'and': [22, 51, 68, 111, 130, 164, 220, 342], 'double': [23], 'strand': [24], 'breaks': [25], '(DSB)s,': [26], 'PARP1': [27, 367], 'rapidly': [29], 'recruited': [30], 'to': [31, 90, 103, 112, 118, 134, 209, 223, 260, 306, 360, 422], 'altered': [32, 372, 383], 'sites': [34], 'were': [35], 'its': [36], 'catalytic': [37], 'activity': [38, 69, 370, 373, 391], 'produces': [39], 'protein-conjugated': [40], 'long-branched-poly-ADP-ribose': [41], '(PAR)': [42], 'chains.': [43], 'These': [44], 'protein': [45, 99], 'modifications': [46], 'result': [47], 'in': [48, 57, 95, 108, 120, 149, 155, 183, 190, 225, 237, 247, 253, 277, 283, 288, 334, 340, 400, 450], 'the': [49, 66, 136, 144, 156, 173, 198, 203, 214, 226, 298, 316, 321, 335, 352, 389, 407, 417, 457, 462], 'recruitment': [50], 'activation': [52], 'multiple': [54], 'proteins': [55, 116, 378], 'involved': [56, 282], 'repair.': [59, 97], 'Although': [60], 'there': [61, 72], 'considerable': [63], 'research': [64], 'describing': [65], 'characteristics': [67], 'PARP1/2,': [71], 'are': [73, 80, 258], '15': [74], 'other': [75], 'PARP': [76], 'family': [77], 'members': [78], 'that': [79, 172, 297], 'less': [81], 'well': [82], 'characterized.': [83], 'Of': [84], 'these': [85, 248, 292], 'PARP3': [86, 139, 146, 200, 267, 299, 414, 433, 448], 'has': [87, 100], 'been': [88, 101], 'shown': [89, 102], 'have': [91, 104], 'a': [92, 105, 193, 233, 241, 401], 'distinct': [93], 'role': [94, 107, 137], 'This': [98, 279], 'critical': [106], 'DSB': [109], 'resolution': [110], 'interact': [113], 'with': [114, 151, 192, 326, 396], 'partner': [115], 'know': [117], 'function': [119], 'classical': [121], 'nonhomologous': [122], 'end': [123], 'joining': [124], '(NHEJ)': [125], 'such': [126], 'as': [127], 'DNA-PKcs,': [128], 'Ku70,': [129], 'Ku80.': [131], 'In': [132, 211], 'order': [133], 'examine': [135], 'vis-à-vis': [140], 'chemotherapy,': [141], 'we': [142, 295], 'utilized': [143, 333], 'specific': [145, 199, 234, 432], 'inhibitor,': [147, 300], 'ME-0328': [148, 202, 229, 284, 301, 325, 356, 399], 'combination': [150, 191], 'activated': [152], 'cyclophosphamide': [153], '(4HC)': [154], 'chronic': [157], 'lymphocytic': [158], 'leukaemia': [159], '(CLL)': [160], 'cell': [161, 249, 344, 409], 'lines,': [162], 'MEC1': [163], 'MEC2.': [165], 'Results': [166], 'from': [167], 'MTT': [168], 'cytotoxicity': [169, 246], 'assays': [170], 'showed': [171], '50%': [174], 'inhibitory': [175], 'concentration': [176, 195], '(IC50)': [177], '(50%': [178], 'control)': [180], '4HC': [182, 206, 217, 245, 251, 287, 327, 361, 393], 'MEC-1': [184], 'cells': [185, 213, 359, 421], 'was': [186, 207, 218, 221], '12.9μM.': [187], 'When': [188], 'used': [189], 'nontoxic': [194], '(2μM)': [196], 'inhibitor': [201, 236], 'IC50': [204, 215], 'reduced': [208, 222], '3.3μM.': [210], 'MEC-2': [212], '10.8μM': [219], '2.1μM': [224], 'presence': [227], 'at': [230], '2μM.': [231], 'ABT-888,': [232], 'PARP1/2': [235], 'clinical': [238, 348, 436], 'trials': [239], 'had': [240], 'minimal': [242], 'effect': [243], 'on': [244], 'lines.': [250], 'results': [252, 294, 427], 'interstrand': [254], 'crosslinks': [255], '(ICLs)': [256], 'which': [257, 355], 'believed': [259], 'be': [261, 281], 'repaired': [262], 'by': [263, 354], 'homologous': [264], 'recombination.': [265], 'Intriguingly,': [266], 'negatively': [268], 'regulates': [269], 'class': [270], 'switch': [271], 'recombination': [272], 'via': [273], 'activation-induced': [274, 384], 'cytidine': [275, 385], 'deaminase': [276], 'B-lymphocytes.': [278], 'may': [280, 415], 'sensitization': [285, 323], 'B-lymphocytic': [289, 304], 'malignancies.': [290], 'Given': [291], 'preliminary': [293], 'hypothesize': [296], 'will': [302, 314], 'sensitize': [303], 'cancers': [305], 'chemotherapies.': [307, 425], 'To': [308], 'explore': [309], 'this': [310, 312], 'hypothesis': [311], 'project': [313], 'pursue': [315], 'following': [317], 'objectives:': [318], '1.': [319], 'Characterize': [320], 'selective': [322], 'and/or': [328, 362, 371, 382, 394], 'bendamustine': [329, 363, 395], '(an': [330], 'ICL-inducing': [331], 'drug': [332], 'treatment': [336], 'B-lymphocyte': [338], 'malignancies)': [339], 'B-lymphoma': [341], 'CLL': [343, 347, 358], 'lines': [345], 'plus': [346], 'samples.': [349], '2.': [350], 'Determine': [351, 388], 'mechanisms': [353], 'sensitizes': [357], '(i.e.': [364], 'reduction': [365], 'or': [368, 397], '3': [369], 'known': [375], 'repair': [377], '(Rad51,': [379], 'DNA-PK,': [380], 'H2AX)': [381], 'deaminase).': [386], '3.': [387], 'in-vivo': [390], 'without': [398], 'Rag2': [402], '/-γcc-/-': [403], 'xenograft': [404], 'model': [405], 'using': [406], 'MEC1-CLL': [408], 'line.': [410], 'The': [411], 'inhibition': [412], 'increase': [416], 'sensitivity': [418], 'tumor': [420], 'damaging': [424], 'Our': [426], 'should': [428], 'stimulate': [429], 'development': [430], 'inhibitors': [434, 449], 'for': [435, 465], 'use.': [437], 'Citation': [438], 'Format:': [439], 'Bahram': [440], 'Sharif-Askari,': [441], 'David': [442], 'Davidson,': [443], 'Lilian': [444], 'Amrein,': [445], 'Lawrence': [446], 'Panasci.': [447], 'cancer': [451], 'therapy.': [452], '[abstract].': [453], 'In:': [454], 'Proceedings': [455], '107th': [458], 'Annual': [459], 'Meeting': [460], 'American': [463], 'Association': [464], 'Cancer': [466, 477], 'Research;': [467], '2016': [468], 'Apr': [469], '16-20;': [470], 'New': [471], 'Orleans,': [472], 'LA.': [473], 'Philadelphia': [474], '(PA):': [475], 'AACR;': [476], 'Res': [478], '2016;76(14': [479], 'Suppl):Abstract': [480], 'nr': [481], '268.': [482]}, 'cited_by_api_url': 'https://api.openalex.org/works?filter=cites:W2503626267', 'counts_by_year': [], 'updated_date': '2024-12-12T10:04:41.132262', 'created_date': '2016-08-23'}